MedTrace Logo

Laboratory Study of Early Tumor Markers in the Peripheral Blood of Glioblastoma Multiforme Patients

NCT01135875 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 130

Last updated 2013-10-17

No results posted yet for this study

Summary

The purpose of this study is to determine if tumor cells can be detected in the blood of patients diagnosed with a brain tumor.

Conditions

Interventions

OTHER

GBM Patients

2 teaspoons of blood will be collected during select clinic visits.

OTHER

Normal Controls

2 teaspoons of blood will be collected once.

Sponsors & Collaborators

  • University of Florida

    lead OTHER

Principal Investigators

  • Brent Reynolds, PhD · University of Florida

Eligibility

Min Age
18 Years
Max Age
89 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2013-04-30
Completion
2013-04-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01135875 on ClinicalTrials.gov